We are a Swiss specialty pharmaceutical company committed to developing and commercializing innovative medicines to meet the needs of patients living with rare and other diseases with high unmet medical needs. Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company that has dedicated more than a decade to researching effective medicines for rare neuromuscular and pulmonary diseases th
at currently lack treatment options. We are passionate about improving patients’ quality of life. Community Guidelines:
All users must comply with Facebook's terms of use (https://www.facebook.com/legal/terms) and these community guidelines. Please refer to your country’s guidelines for information on sharing
content. The views and opinions expressed by members of this community are not reflections of Santhera Pharmaceuticals. Santhera Pharmaceuticals does not endorse the information or opinions expressed or shared by members of this community. Santhera Pharmaceuticals expressly disclaims all liability. Content on this page may contain information related to various medical conditions, but this information is not intended to replace the advice of your doctor. You should always consult your provider for medical advice. We do not intend to censor audience postings. However, as the healthcare space is heavily governed, we can't engage in sensitive topics, discussion(s) about products - ours or other companies' - or treatment options on this page.
-If your comment contains any of the following or doesn't comply with these rules, it may be removed:
-If your posts are product related. Reporting product related adverse events or product complaints, or submitting product related medical enquiries should not be done through this forum. Guidance on reporting product
related adverse events or submitting medical enquiries is provided below;
-If your posts include profanity, defamatory, libelous, offensive, abusive, discriminatory or demeaning content (including images, videos and links);
-If your posts offer health or medical advice;
-If your posts contain any personal information e.g. names of individuals, email addresses or phone numbers;
-If your posts violate another's copyright or intellectual property;
-If your posts are commercial, e.g. sell products and services, or recruit fans and followers;
-If your posts are excessively repetitive and/or disruptive to the community or are spam;
-If your posts contain proprietary, confidential, sensitive, or nonpublic information;
-If your posts don't follow Facebook's posting guidelines and Terms of Use;
Non-English language
Privacy Statements:
Please note that Facebook also has access to information you share with us through their platform. For more details please refer to the Facebook Privacy Policy. Please visit us at our website for further information about our company: http://www.santhera.com/
Safety Statements:
Reporting suspected adverse reactions after authorization of the medicinal product is important as this will allow quick identification of new safety information. Please report any suspected adverse reactions to Raxone® (idebenone) to your Health Authorities if required by the local regulations in your country as well as to the manufacturer of the product via email: santhera@EU.propharmagroup.com, unless prohibited by the regulations.